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TRiC controls transcription resumption after UV
damage by regulating Cockayne syndrome protein
A
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Transcription-blocking DNA lesions are removed by transcription-coupled nucleotide exci-
sion repair (TC-NER) to preserve cell viability. TC-NER is triggered by the stalling of RNA
polymerase II at DNA lesions, leading to the recruitment of TC-NER-speciﬁc factors such as
the CSA–DDB1–CUL4A–RBX1 cullin–RING ubiquitin ligase complex (CRLCSA). Despite its vital
role in TC-NER, little is known about the regulation of the CRLCSA complex during TC-NER.
Using conventional and cross-linking immunoprecipitations coupled to mass spectrometry,
we uncover a stable interaction between CSA and the TRiC chaperonin. TRiC’s binding to
CSA ensures its stability and DDB1-dependent assembly into the CRLCSA complex. Conse-
quently, loss of TRiC leads to mislocalization and depletion of CSA, as well as impaired
transcription recovery following UV damage, suggesting defects in TC-NER. Furthermore,
Cockayne syndrome (CS)-causing mutations in CSA lead to increased TRiC binding and a
failure to compose the CRLCSA complex. Thus, we uncover CSA as a TRiC substrate and
reveal that TRiC regulates CSA-dependent TC-NER and the development of CS.
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Environmental pollutants, radiation, and cellular metaboliteshave the propensity to damage DNA and promote genomeinstability and age-related diseases1. The versatile nucleotide
excision repair (NER) pathway is an important defense
mechanism, which removes a remarkably wide spectrum of
DNA-helix destabilizing lesions, including those induced by UV
irradiation, via two distinct damage-recognizing sub-pathways:
global genome NER (GG-NER) and transcription-coupled NER
(TC-NER). While GG-NER removes DNA damage from the
entire genome, TC-NER speciﬁcally targets transcription-
blocking DNA lesions, thereby preserving transcription pro-
grams2,3. TC-NER is initiated by the stalling of RNA polymerase
II at DNA lesions. This triggers the recruitment of the SNF2/
SWI2 ATPase CSB and the CSA protein, which promote the
assembly of a large repair complex that unwinds the damaged
DNA, excises a single-stranded DNA region containing the
lesion, and promotes DNA synthesis and ligation to seal the
gap4,5.
CSA comprises a seven-bladed WD40 propeller that, through
interactions with DDB1, assembles into a cullin-RING ubiquitin
ligase (CRL) complex with CUL4A/B and RBX1 (CRLCSA)6.
CRLCSA binds the COP9 signalosome (CSN) complex7, which
renders CUL4A inactive through deneddylation. Following UV
damage, COP9 is likely displaced by CSB when CSA becomes
incorporated into the TC-NER complex, triggering CUL4A acti-
vation by neddylation6. This process is thought to lead to poly-
ubiquitination and subsequent proteasome-dependent degrada-
tion of CSB6,8. UVSSA on the other hand stabilizes CSB by
counteracting its CSA-dependent ubiquitylation by recruiting the
broad-spectrum deubiquitinating enzyme USP79–11. In this way,
CRLCSA and UVSSA-USP7 act antagonistically to coordinate the
timely removal of CSB from transcription-blocking lesions,
allowing efﬁcient restart of transcription following TC-NER.
Genetic defects in CSA and CSB mostly give rise to Cockayne
syndrome, which is a multisystem-disorder characterized by
premature aging, progressive mental and sensorial retardation,
microcephaly, severe growth failure, and cutaneous photo-
sensitivity12. Despite the important role of CSA in controlling
TC-NER and preventing adverse effects on health, remarkably
little is known about the regulation of CSA in the context of the
CRLCSA complex.
Here we use conventional and cross-linking immunoprecipi-
tations coupled to mass spectrometry to uncover proteins that
bind and regulate the function of CSA. Using this approach, we
identify several new CSA-interacting proteins, including all sub-
units of the TRiC complex. TRiC is a eukaryotic chaperonin that
has evolved to ensure proteome integrity of essential and topo-
logically complex proteins, including cell-cycle regulators, sig-
naling proteins, and cytoskeletal components13,14. We ﬁnd that
TRiC’s binding to CSA ensures its proper folding and DDB1-
dependent assembly into the CRLCSA complex. Consequently,
loss of functional TRiC affects CSA’s localization and stability,
and impairs transcription recovery after DNA damage induction.
These ﬁndings show that CSA is a TRiC substrate and reveal a
role for the TRiC chaperonin in regulating CSA-dependent TC-
NER.
Results
CSA interacts with chaperonin TRiC. To identify CSA reg-
ulating proteins, we stably expressed FLAG-tagged CSA in CSA-
deﬁcient patient cells (CS3BE-SV40), and performed a pulldown
of CSA-FLAG followed by mass spectrometry (MS). Among the
top hits were known interactors of CSA, such as the members of
the COP9 signalosome (e.g., COPS2 and COPS3) and the
CRLCSA complex (e.g., DDB1 and CUL4A), as well as the TC-
NER proteins CSB and UVSSA2,6,7,15 (Supplementary Data 1).
Unexpectedly, our approach also identiﬁed all eight subunits of
the TRiC chaperonin complex as CSA-interacting factors (Fig. 1a
and Supplementary Data 1). A FLAG pulldown from cells
expressing CSA-FLAG followed by western blot analysis con-
ﬁrmed the interaction between CSA and the TRiC subunit TCP1
(Fig. 1b). Moreover, immunoprecipitation of CSA from human
ﬁbroblasts followed by western blot analysis conﬁrmed a UV-
independent interaction between CSA and TCP1 at the endo-
genous level, as well as the known UV-dependent interaction with
the elongating form of RNAPII (RNAPIIo)16 (Fig. 1c). Finally,
pulldown of CSA-GFP from CSA-deﬁcient patient cells con-
ﬁrmed interactions between CSA and the TRiC subunits CCT4
and CCT5 (Fig. 1d, e). These results demonstrate that CSA
interacts with the TRiC complex.
We then addressed if the CSA-TRiC complex is distinct from
the CRLCSA complex by performing a tandem pulldown of CSA-
FLAG and DDB1-GFP from U2OS cells that co-expressed these
fusion proteins. Pulldown of CSA-FLAG conﬁrmed interactions
with both GFP-DDB1 and CUL4A, as well as TRiC components
CCT4 and CCT7 (Fig. 1e). Importantly, subsequent speciﬁc
enrichment of CRLCSA by pulldown of GFP-DDB1 revealed an
interaction with CUL4, but not with CCT4 or CCT7 (Fig. 1e).
We therefore conclude that TRiC preferentially interacts with
CRL-free CSA.
CSA binds the inner pocket of TRiC. TRiC/CCT (TCP1 ring
complex/chaperonin containing TCP1) is an ATP-dependent
complex composed of two stacked octameric rings. Each ring
consists of eight different but related subunits, which are present
once per ring17. Moreover, each ring creates an inner pocket
where substrate proteins interact to become properly folded18,19.
To gain more insight into the interaction between CSA and TRiC,
we stably expressed CSA-GFP in CSA-deﬁcient patient cells, and
identiﬁed CSA interacting proteins using a label-free quantiﬁca-
tion (LFQ), GFP-Trap afﬁnity puriﬁcation (AP)-MS/MS
approach (Fig. 2a). Even after stringent washing at 1 M NaCl and
1% NP-40, the interaction between CSA and DDB1, CUL4A,
RBX1, and members of the COP9 signalosome was preserved.
Importantly, the LFQ analysis also detected all subunits of the
TRiC complex, indicating that the CSA–TRiC interaction is
highly stable. Moreover, the use of ethidium bromide excludes the
possibility that these interactions are mediated by DNA, which is
in agreement with our observation that most CSA-TRiC com-
plexes are found in the soluble fraction of the cell (Fig. 1b, c).
Finally, we used an iBAQ-based method20 to estimate the relative
stoichiometries of the various proteins immunoprecipitated by
CSA. This revealed an interaction stoichiometry of ~1 TRiC
subunit per 3 CSA proteins (Fig. 2b).
To examine whether the strong nature of the CSA–TRiC
interaction is mediated by other proteins or can be ascribed to
direct binding of CSA to TRiC, we applied xIP-MS21. Immuno-
precipitation of CSA-GFP by GFP-TRAP was followed by on-
bead cross-linking and tryptic digestion of the bound proteins
into covalently cross-linked peptides. Identiﬁcation of cross-
linked peptides was performed using pLink22 after analysis by
mass spectrometry, which revealed residues in close spatial
proximity. We identiﬁed 149 unique, high conﬁdence residue
cross-links in total (Fig. 2c and Supplementary Data 2). Of these,
62 linkages were intra- or inter-linkages mapping to subunits of
the TRiC complex (Supplementary Fig. 1a). All of these TRiC
cross-links were consistent with a cross-linker spacer length
of less than 34 Å, conﬁrming the structural validity of our data
(Supplementary Fig. 1b). Importantly, we observed 11 cross-links
between CSA and TRiC subunits CCT3, CCT4, and CCT6
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involving CSA residues Lys34, Lys85, Lys167, and Lys212
(Fig. 2c). Although this does not provide information about
speciﬁc residues that mediate the interaction, the location of these
lysine residues in the outer regions of the β-propeller blades made
up by the WD40 domain of CSA suggests that these regions are
important for the interaction with TRiC (Supplementary Fig. 4a).
Given these inter-protein linkages as distance restraints, we used
DisVis23 to identify the accessible interaction space for CSA on
the TRiC surface (Fig. 2d). Our data indicate that the only
available interaction space for CSA that is consistent with our
cross-linking data is within TRiC’s inner pocket.
Loss of TRiC components reduces CSA stability. TRiC has been
described to be involved in the folding or stabilization of ~10% of
all newly synthesized proteins24. Among the known TRiC sub-
strates are many WD40 repeat-containing proteins. Given that
CSA contains seven of such repeats and considering our obser-
vation that TRiC directly interacts with CSA, we hypothesized
that TRiC could be important for proper folding of CSA and
consequently for its stability. To assess this, we depleted TCP1
using siRNAs and examined CSA levels in whole cell extracts by
western blot analysis at different times after siRNA transfection
(Fig. 3a, b and Supplementary Fig. 2a,b). TCP1 knockdown
resulted in a marked decrease in the overall amount of CSA when
a
d e
c
bCS3BE-SV40 
+ FLAG
light (L)
CS3BE-SV40
+ CSA-FLAG
heavy (H)
FLAG pulldown +
mass spectometry
Proteins Peptides Ratio H/L
CSA 17
25
35.1
13.8TCP1
31CCT2
24CCT3
22CCT4
31CCT5
19CCT6
25CCT7
31CCT8
46DDB1
1RBX1
42CUL4A
32CUL4B
33CSB
5UVSSA
16.2
19.8
27.3
17.3
16.9
24.6
12.1
17.5
17.9
16.9
7.1
6.9
5.8
CSA-FLAG
FLAG
UV – + – + – + – +
+ + – – + + – –
– – + + – – + +
– + – + – + – +
+ + – – + + – –
– – + + – – + +
Soluble fraction Solubilized chromatin
Input Pulldown: FLAG Pulldown: FLAGInput
DDB1
TCP1
CSA
Soluble fraction Solubilized chromatin
UV
αCSA in IP
– + + – + +
+ + – + + –
Input IP: CSA
– + + – + +
+ + – + + –
Input IP: CSA
RNAPIIo
DDB1
CUL4A
TCP1
CSA
GFP-DDB1
CSA-FLAG
GFP –
+
+
––
++–
+
Input
–
+
+
––
++–
+
Pulldown: FLAG
–
+
+
––
++–
+
Pulldown: GFP
CUL4A
GFP-DDB1 
(αGFP)
CCT4
CCT7
CSA (αFLAG)
GFP
CSA-GFP
GFP +
–
–
+
–
+–
+
DDB1
CCT4
CSA (αGFP)
GFP
Input Pulldown: GFP
DDB1
CCT5
CSA (αGFP)
GFP
Fig. 1 CSA interacts with chaperonin TRiC. a A SILAC-mass spectrometry approach identiﬁed all TRiC subunits as CSA-interacting proteins. CSA-deﬁcient
CS3BE-SV40 cells expressing FLAG or CSA-FLAG were cultured in medium containing light or heavy lysine and arginine isotopes, respectively. FLAG- and
CSA-FLAG-interacting proteins were pulled down and samples were processed and analyzed by mass spectrometry. The table shows the number of unique
peptides found for the top ranked interactors, as well as the ratio of the interactor in the CSA-FLAG pulldown to that in the control FLAG pulldown
(ratio H/L). b FLAG pulldowns conﬁrm the UV-independent interaction between CSA-FLAG and TCP1. CS3BE-SV40 cells expressing FLAG or CSA-FLAG
were mock-treated or UV-C irradiated (20 J/m2). After 1 h of recovery cells were lysed and fractionated into soluble or solubilized chromatin. FLAG
pulldowns using both fractions were followed by western blot analysis for the indicated proteins. c CSA co-immunoprecipitation conﬁrms the interaction
between endogenous CSA and TCP1. As in b, except that VH10-hTert cells were used and that endogenous CSA was immunoprecipitated. d GFP
pulldowns conﬁrm the interaction between CSA and TRiC subunits CCT4 and CCT5. GFP or CSA-GFP was pulled down from CS3BE-SV40 cells. e Tandem
FLAG and GFP pulldowns show preferential binding of TRiC to DDB1/CUL4A/RBX1-free CSA. CSA-FLAG, GFP, and GFP-DDB1 were expressed in U2OS
cells as indicated. Enrichment of CSA-interacting proteins by means of FLAG pulldowns conﬁrmed interactions between CSA and DDB1 and CUL4A, as well
as the TRiC subunits CCT4 and CCT7. Subsequently, eluted protein complexes were subjected to pulldown of GFP-DDB1, revealing an interaction with
CUL4A, but not CCT4 and CCT7. Full-size scans of western blots are provided in Supplementary Fig. 7
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compared to control cells treated with siRNAs against Luciferase,
whereas the levels of DDB1 remained unaffected. The reduction
in CSA levels correlated with the knockdown efﬁciency of TCP1.
Knockdown of a single TRiC component has been shown to
negatively impact the stability of other subunits in the complex25,
thereby lowering the availability of functional TRiC complexes in
the cell. To conﬁrm that our observations are not speciﬁc for
TCP1 knockdown, but are the consequence of the loss of TRiC
complexes, we also examined the effect of CCT4, CCT5, and
CCT7 depletion on CSA protein abundance. Knockdown of these
a
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TRiC subunits using different siRNAs also caused a reduction in
the CSA levels (Fig. 3c and Supplementary Fig. 2c). Similarly,
treatment with a TRiC inhibitor (TRiCi), which has been shown
to inhibit archaeal TCP1 activity in vitro26, led to a substantial
decrease in CSA levels while not affecting TCP1 levels itself
(Fig. 3d). This shows that CSA stability is not only negatively
affected by the loss of TRiC protein, but also by inhibition of its
chaperonin activity. To validate these ﬁndings, we expressed
CSA-GFP in CSA-deﬁcient patient cells and examined the effect
of TCP1 and CCT4 knockdown on CSA-GFP expression by
ﬂuorescence microscopy analysis. Similar to endogenous CSA, we
found that CSA-GFP is primarily expressed in the nucleus.
Depletion of either TCP1 or CCT4 signiﬁcantly reduced the levels
of CSA-GFP in the nucleus (Fig. 3e). This reduction in CSA-GFP
protein levels is consistent with the effect on endogenous CSA as
observed by western blot analysis (Fig. 3a–c and Supplementary
Fig. 2). Taken together, these ﬁndings indicate that the TRiC
complex is involved in regulating CSA stability, likely by affecting
proper folding of CSA.
TRiC is involved in the formation of the CRLCSA complex. CSA
is a stable component of the DDB1- and RBX1-containing
CRLCSA complex. In this complex, it directly associates with
DDB16 and likely functions as the substrate receptor. Considering
that TRiC is required for CSA stability, we wondered whether
DDB1 acts as an acceptor of TRiC-bound CSA in the CRLCSA
complex. To test this, we ﬁrst pulled down CSA-GFP from CSA-
deﬁcient patient cells that were treated with siRNAs against
DDB1. Knockdown of DDB1 not only led to a decrease in the
association of CSA with DDB1 and CUL4A, but also negatively
affected the binding to CSB (Fig. 4a). Strikingly, however, the
efﬁciency by which CSA binds to the TRiC subunit TCP1
appeared to be substantially increased, suggesting that DDB1 may
serve as an acceptor of CSA. Secondly, we created a mutant, CSA
ΔN, which lacks the ﬁrst 21 amino acids required for DDB1
binding6 (Fig. 4b), which was stably expressed in CRISPR/Cas9-
mediated CSA knockout U2OS cells (Fig. 4c). Pulldown of GFP-
tagged CSA ΔN from these cells not only showed the expected
decrease in DDB1 binding as compared to CSA WT, but also
abolished the interaction with CSB (Fig. 4d). Importantly, the
interaction between CSA ΔN and TCP1 was substantially
increased as compared to full-length CSA (Fig. 4d). These results
show that interfering with the CSA–DDB1 interaction, either by
depletion of DDB1 or deletion of the DDB1-interacting domain
in CSA, strongly enhances the interaction between CSA and
TRiC. This suggests that in the absence of DDB1, CSA remains
tightly bound to the TRiC complex and that DDB1 serves as an
acceptor of TRiC-bound CSA in the CRLCSA complex.
Next, we studied the effect of DDB1 loss on the expression and
localization of CSA-GFP following its expression in CSA-deﬁcient
patient cells by ﬂuorescence microscopy analysis. DDB1
knockdown led to a signiﬁcant decrease in nuclear CSA-GFP
levels, while CSA-GFP levels in the cytoplasm increased (Fig. 4e),
likely due to persistent binding of CSA-GFP to TRiC (Fig. 4a).
The latter is consistent with the fact that TRiC is a chaperonin
that primarily localizes to and functions in the cytoplasm.
Together our ﬁndings suggest a hand-over mechanism in which
cytoplasmic TRiC provides properly folded CSA to DDB1,
thereby facilitating its assembly into CRLCSA complexes that
translocate into the nucleus. Hand-over of CSA might occur
directly after its release by TRiC in the cytoplasm, as we detected
TRiC-bound, as well as DDB1-bound cytoplasmic CSA (Supple-
mentary Fig. 3).
A CSA mutant of the top platform shows increased TRiC
binding. The four residues in CSA that were revealed by xIP-MS
to be in proximity of the CSA-TRiC binding interface surround a
platform at the top of CSA that is formed by the β-propeller
blades6 (Supplementary Fig. 4a and Supplementary Data 2). In
order to further assess the functional relevance of the CSA-TRiC
interaction, we created eight different CSA mutants in which one
of the residues Glu103, Phe120, Lys122, Arg164, Lys247, Lys292,
Lys293, or Arg354 in this platform was substituted by Alanine
(Supplementary Fig. 4a). Immunoprecipitation of these mutants
from CSA-deﬁcient patient cells did not reveal any major dif-
ference in their interaction with TCP1, as well as the CRLCSA
complex members DDB1 and CUL4A, as compared to wildtype
CSA (Supplementary Fig. 4b). Accordingly, expression of each
mutant could also rescue the UV sensitivity of the CSA-deﬁcient
patient cells (Supplementary Fig. 4c). Aiming to induce a greater
effect on CSA, we next generated a CSA mutant (CSA 8M) that
contains all the eight afore-studied mutations in the top platform.
Since according to the 3D structure of CSA–DDB16 this platform
of CSA is not directly involved in DDB1 binding (Figs. 4b and
5a), we expected that the combined eight mutations would leave
the CRLCSA intact (Fig. 5a, b). Surprisingly, however, pulldown of
GFP-tagged CSA WT and CSA 8M from CSA-deﬁcient patient
cells showed decreased binding of CSA 8M to CSB, DDB1, and
CUL4A when compared to CSA WT (Fig. 5c). This indicated that
the mutations impacted CSA’s interactions in a manner similar to
DDB1 depletion or deletion of the DDB1-interacting domain in
CSA (Fig. 4a, d). We therefore wondered whether the altered
interactions observed for CSA 8M could be explained by, or lead
to a change in TRiC binding. Indeed, CSA 8M showed greatly
increased binding to TCP1 when compared to CSA WT (Fig. 5c).
Given that the mutated residues do not directly bind to DDB1, we
consider it most plausible that the mutations negatively affect the
release of CSA by TRiC. This is strengthened by ﬂuorescence
microscopy-based analysis of CSA 8M expression, which revealed
that this mutant largely fails to localize to the nucleus and
remains mainly cytoplasmic (Fig. 5d), a phenotype reminiscent of
that observed after DDB1 knockdown (Fig. 4e). This corroborates
Fig. 3 Loss of TRiC components reduces CSA stability. a Depletion of TCP1 decreases CSA protein abundance. VH10-hTert cells were transfected with the
indicated siRNAs and total cell extracts were prepared at the indicated time points after siRNA transfection. Protein levels were determined by western blot
analysis of the indicated proteins. H3 is a loading control. Graphs represent the ratio of protein signal intensities over H3 control signal intensities for
siTCP1-treated cells relative to that for siLuc-treated control cells, which was set to 100%, at each time point. A repeat of the experiment is shown in
Supplementary Figure 2a. b Depletion of TCP1 decreases CSA protein abundance. As in a, except that two different siRNAs against TCP1 were used and
that protein levels were determined 72 h after siRNA transfection. A repeat of the experiment is shown in Supplementary Figure 2b. c Depletion of CCT4,
CCT5, or CCT7 decreases CSA protein abundance. As in a, except that CCT4, CCT5, or CCT7 siRNAs were used and that protein levels were determined
72 h after siRNA transfection. A repeat of the experiment is shown in Supplementary Figure 2c. d TRiC inhibition decreases CSA protein abundance. VH10-
hTert cells were treated with DMSO or an inhibitor against the TRiC subunit TCP1 (TRiCi). Protein levels were determined after 72 h of treatment. e TCP1
or CCT4 loss decreases CSA-GFP protein abundance in the nucleus. TCP1 or CCT4 was depleted from CSA-GFP expressing CS3BE-SV40 cells using the
indicated siRNAs. Nuclear and cytoplasmic CSA-GFP levels were analyzed and quantiﬁed by ﬂuorescence microscopy and ImageJ. GFP signal intensities
were normalized to the average nuclear signal in siLuc-treated cells. Data represent mean ± SEM of 190 cells quantiﬁed in two independent experiments. p-
Values were derived from an unpaired t-test. Length of scale bar: 10 µm. Full-size scans of western blots are provided in Supplementary Fig. 8
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our conclusion that cytoplasmic TRiC provides properly folded
CSA to DDB1 for incorporation into CRLCSA complexes and
subsequent translocation into the nucleus.
Loss of TRiC reduces RRS and protection against UV damage.
The CRLCSA complex is a nuclear core component of the TC-
NER machinery. Since TRiC is critical for regulating CSA stability
and formation of the CRLCSA complex, we asked if the TRiC-
dependent regulation of CSA is a prerequisite for functional TC-
NER. Indeed, we found that the recovery of RNA synthesis (RRS)
after global UV-irradiation, which is an established measure for
TC-NER, was impaired in TCP1-depleted cells when compared to
control cells (Fig. 6a), while basal transcription levels remained
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unaffected by TCP1 knockdown (Supplementary Fig. 5a). A
similar effect on RRS could be observed after knockdown of
CCT4, CCT5, or CCT7 (Supplementary Fig. 5b). In contrast,
depletion of several individual TRiC subunits did not affect GG-
NER, as determined by measuring DNA repair synthesis (Sup-
plementary Fig. 5c,d). Furthermore, we found that in CSA-
deﬁcient patient cells expressing CSA 8M RRS was reduced when
compared to that in cells expressing CSA WT (Fig. 6b), showing
that not only CSA instability, but also persistent binding of CSA
to TRiC negatively impacts TC-NER. In agreement with a defect
in TC-NER, we also observed that TCP1-depleted cells, as well as
cells depleted of several other individual TRiC subunits, were
markedly more sensitive to UV when compared to control cells as
measured in alamarBlue-based viability assays (Fig. 6c and Sup-
plementary Fig. 6a). Notably, overexpression of CSA partially
alleviated the UV sensitivity of TCP1-depleted cells, suggesting
that this phenotype is largely due to loss of CSA stability and not
that of another TRiC substrate (Supplementary Fig. 6b). More-
over, expression of mutant CSA 8M in patient cells failed to
complement the relatively high UV sensitivity caused by CSA
deﬁciency, whereas expression of CSA WT could do so, as
determined in clonogenic survival assays (Fig. 6d, Supplementary
Fig. 6c). Finally, expression of CSA ΔN in CSA knockout U2OS
cells could not rescue the extreme sensitivity of these cells to
Illudin S, which is an agent that induces transcription-blocking
DNA lesions that are repaired by TC-NER27, whereas expression
of CSA WT fully rescued this phenotype (Fig. 6e). Together these
data show that TRiC, by regulating CSA stability and incor-
poration into the CRLCSA complex, promotes TC-NER and
protects cells against UV-induced damage.
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Patient mutations in CSA cause increased TRiC binding.
Mutations in the CSA gene have been found to underlie the
multi-system disorder Cockayne syndrome (CS). CS patients
suffer from cutaneous photosensitivity and severe neurological
and developmental defects12. Although part of the cases can be
explained by mutations that lead to a non-functional and/or
truncated CSA protein, it remains to be established how a group
of single missense mutations can give rise to CS. Importantly, the
majority of these mutations are present in the WD40 repeats of
CSA that we discovered to be important for the interaction with
TRiC (Fig. 2 and Supplementary Fig. 4a). To unravel the effect of
such disease-causing point mutations on the CSA protein, we
created GFP-tagged CSA constructs harboring patient mutations
A160T, A205P, or D266G, which are found in WD40 repeats 3, 4,
and 5, respectively (Fig. 7a)28. A160T and A205P have been
predicted to interfere with the integrity of the overall fold,
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Fig. 6 Loss of TRiC reduces RRS and protection against UV damage. a TCP1 loss reduces RNA synthesis recovery following UV-C irradiation. VH10-hTert
cells were transfected with the indicated siRNAs and UV-C irradiated (10 J/m2). RNA synthesis was measured by means of EU incorporation at the
indicated time points after UV. RNA synthesis levels were normalized to those in non-irradiated cells, which were set to 100%. Data represent the mean ±
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WT. As in a, except that CS3BE-SV40 cells expressing CSA-FLAG WT or CSA-FLAG 8M were used. Data represent the mean ± SEM of four independent
experiments. c TCP1 loss renders cells hypersensitive to UV damage. VH10-hTert cells were transfected with the indicated siRNAs, UV-C irradiated at the
indicated doses and 72 h later assayed for viability using alamarBlue®. Data represent mean ± SEM of four independent experiments. d Expression of CSA-
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whereas D266G is expected to have mostly local effects6. Inter-
estingly, pulldown of these mutants from U2OS cells revealed
substantially increased TRiC binding as compared to wild-type
CSA, suggesting misfolding of the mutated CSA proteins
(Fig. 7b). Moreover, none of the three mutants appeared to adopt
a conformation suitable for incorporation into the CRLCSA
complex, as reﬂected by the lack of DDB1 and CUL4A binding.
Fluorescence microscopy further illustrated that whereas wildtype
CSA was translocated into the nucleus, all three mutants were
predominantly present in the cytoplasm (Fig. 7c), indicating that
these patient mutations lead to a CSA protein that fails to localize
to the nucleus. Thus, we provide evidence that disease-associated
missense mutations in CSA can lead to enhanced interaction with
TRiC and cause cellular mislocalization. This underscores the
importance of the TRiC chaperonin in CSA folding/stabilization
and assembly of the CRLCSA complex, as well as in the devel-
opment of CS.
Discussion
A network of chaperones and protein degradation machineries,
called the proteostasis network (PN) is required to maintain
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protein homeostasis29. By regulating protein stability and
degradation in cells, the PN drives vital processes30. Although
several components of the PN have been found implicated in the
DNA damage response31–34, mechanistic insight into how this
network affects these processes has remained largely elusive. Here
we demonstrate that one of the components of the PN, the
chaperonin TRiC, stably interacts with the core TC-NER protein
CSA. By encapsulating CSA in its inner pocket, TRiC ensures its
stability and mediates the incorporation of CSA into the CRLCSA
complex. Our ﬁndings suggest a hand-over mechanism in which
TRiC provides properly folded CSA to DDB1, which is crucial to
enable the formation of the CRLCSA complex and its nuclear
localization. Interfering with the TRiC–CSA interaction, either by
disturbing or strengthening it, lowers the levels of functional CSA
in the nuclear CRLCSA complex and results in impaired recovery
of RNA synthesis and decreased cell viability upon UV-C-
induced DNA damage. Thus, we uncover CSA as a TRiC sub-
strate and reveal a role for the TRiC chaperonin in regulating
CSA-dependent TC-NER.
CSA has been shown to stably interact with DDB16. However,
our iBAQ analysis suggests that approximately 15% of the CSA
protein pool is not bound by DDB1 (Fig. 2b). This fraction of
CSA is likely unstable and/or improperly folded and therefore
bound by TRiC. Consistently, pulldowns of CRLCSA revealed that
TRiC preferentially binds CSA that is not associated with the CRL
complex (Fig. 1e). From our iBAQ analysis, a (DDB1-free) CSA
to TRiC subunit ratio of ~1:2 can be inferred. As every TRiC
complex contains two copies of each of the eight subunits, this
stoichiometry may suggest a model in which one CSA protein is
encapsulated per TRiC complex. Interestingly, this model differs
from the proposed encapsulation mode for the TRiC substrate
tubulin, for which two molecules were shown to bind the complex
simultaneously35. This suggests that TRiC employs different
methods of substrate binding and folding. To fully understand the
constitution and conformation of TRiC in complex with CSA, a
more detailed structural analysis would be required.
Our results suggest that TRiC interacts with CSA through its
WD40 domain, thereby regulating CSA stability. Interestingly,
TRiC has been described to regulate the folding and stability of
several other WD40 domain-containing proteins25,36–42. For
instance, TRiC is required to maintain functional TCAB1, a co-
factor of telomerase. Loss of TRiC leads to mislocalization of
telomerase and a failure to elongate telomeres25. Importantly,
TCAB1 mutations found in patients with dyskeratosis congenita
(DC), which is a stem cell disease caused by defects in telomere
maintenance43, were shown to disrupt TRiC-mediated TCAB1
folding, providing clinical relevance to TRiC’s role in stabilizing
this protein. Mutations in CSA have been mostly linked to CS12.
All types of mutations (missense, nonsense, frameshift, splicing
mutations, as well as large deletions) have been detected in CS
patients44. With the exception of the missense mutations, most
mutations likely lead to the production of a truncated and/or
non-functional CSA protein, providing a plausible explanation
for the cause of CS. Interestingly, the majority of the missense
mutations were found in the seven WD motifs that form the
WD40 domain16,44. Here we show that three of these patient
mutations lead to protein instability, resulting in increased TRiC
binding and consequently a loss of functional CRLCSA-bound
CSA in the nucleus. Whether the other reported disease-causing
missense mutations similarly impact TRiC-mediated folding and
stabilization of CSA remains to be established.
DNA repair defects are a major source of genomic instability.
Given that TRiC by affecting CSA stability contributes to TC-
NER, it may play an important role in preserving genome stability
following UV damage. Whether TRiC generally preserves genome
stability by affecting DNA damage repair pathways other than
TC-NER is not clear and may require the identiﬁcation of addi-
tional, yet to be identiﬁed substrates. However, in support of such
a scenario, it was shown that TRiC regulates the stability of the
p53 tumor suppressor protein that is involved in genome stability
maintenance45. In addition, TRiC was found to regulate the
folding and stability of the WD40 domain-containing CDC20
protein36,46, which is a member of the anaphase-promoting
complex. CDC20 controls cell division and genome integrity and
has been implicated in cancer47. Thus, TRiC likely affects genome
stability maintenance by facilitating the folding of proteins other
than CSA. Future endeavors may shed light on how misregulation
of TRiC generally affects genome instability and contributes to
diseases such as cancer48. Such work may also provide potential
targets for diagnostics and therapeutics for pathological condi-
tions associated with genome instability, such as cancer and
aging-related diseases.
Methods
Cell culture. Cells were cultured in DMEM (Invitrogen) supplemented with 10%
fetal bovine serum (FBS; Bodinco BV) and penicillin/streptomycin (Sigma). The
following cell lines were used: U2OS (ATCC), CS3BE-SV40 (GM01856; Coriell
Institute), CS3BE-hTert (GM01856; Coriell Institute), and VH10-hTert.
Generation of stable cell lines. Constructs encoding CSA-FLAG were established
by cloning CSA cDNA (extended with a FLAG-tag by PCR) into pENTR4
(Invitrogen). GFP-tagged constructs were made by cloning CSA WT or CSA 8M,
which was created by site-directed mutagenesis using the QuickChange
site-directed mutagenesis kit (Agilent), into pENTR1A-GFP-N2 (Addgene).
CSA constructs harboring single amino-acid substitutions E103A, F120A,
K122A, R164A, K247A, K292A, K292A+ K293A, and R354A and a C-terminal
10× -His-tag were created by PCR and cloned into pDONR221. Constructs were
subsequently transferred to pLenti6.3 V5-DEST (pENTR4, pENTR1A-GFP)
or pLenti4 V5-DEST (pDONR221) by Gateway LR Clonase II Enzyme Mix
(Invitrogen). Lentivirus was produced using the pCMV-VSV-G, pMDLg-RRE and
pRSV-REV plasmids (Addgene) and used to infect cells with Polybrene® (Sigma).
Stable integrands were obtained after selection in medium containing blasticidin
(ThermoFisher Scientiﬁc) (pLenti6.3) or zeocin (Invitrogen) (pLenti4).
U2OS Flp-In/T-REx cells, which were generated by Professor J. Parvin using the
Flp-InTM/T-RExTM system (Thermo Fisher Scientiﬁc), were a gift of Dr. S. Pﬁster.
These cells were co-transfected with pLV-U6g-PPB containing an antisense guide
RNA targeting the CSA/ERCC8 gene (5-CCAGACTTCAAGTCACAAAGTTG-3)
from the LUMC/Sigma-Aldrich sgRNA library together with an expression vector
encoding Cas9-2A-GFP (pX458; Addgene #48138). Transfected U2OS Flp-In/T-
REx cells were selected on puromycin for 3 days, plated at low density, after which
individual clones were isolated. Knockout of CSA and the absence of Cas9
integration/stable expression in the isolated clones was veriﬁed by western blot
analysis. The neomycin resistance gene in pcDNA5/FRT/TO-Neo (Addgene
#41000) was replaced with a puromycin resistance gene to generate pcDNA5/FRT/
TO-Puro. A fragment spanning GFP-NLS or GFP-N1 (Clontech) was inserted in
this vector to create pcDNA5/FRT/TO-GFP-NLS-Puro and pcDNA5/FRT/
TO-GFP-N1-Puro, respectively. CSA WT or CSA ΔN (lacking the ﬁrst 21 amino
acids) were ampliﬁed by PCR (primers: CSA WT 5′-CACAATGCTAGCGCCACC
ATGCTGGGGTTTTTGTCCG-3′ and 5′-GCATGGTGAAC TACCGGTGCTCCT
TCTTCATCACTGCTG-3′, CSA ΔN 5′-CTAGTAGAATTCATCGGACG CTAG
CATGGAGTCAACACGGAGAGTTTTGG-3′ and 5′-GCACCGACGACCTAGG
CAGGATCCAGACTTCAAGTCACAAAG-3′) and inserted into pcDNA5/FRT/
TO/GFP-N1-Puro. One of the CSA knockout clones was subsequently used to
stably express GFP-NLS, CSA-GFP WT or CSA–GFP ΔN by co-transfection of
pCDNA5/FRT/TO-Puro plasmid encoding these CSA variants (2 µg), together
with pOG44 plasmid encoding the Flp recombinase (0.5 µg). After selection on
puromycin, single clones were isolated and expanded. Isolated U2OS CSA
knockout clones stably expressing CSA-GFP WT or CSA–GFP ΔN were selected
based on their equal and near-endogenous expression levels.
Generation and expression of CSA patient mutants. CSA cDNA was cloned into
pEGFP-N2 (Addgene). Mutations A160T, A205P, and D266G were created by site-
directed mutagenesis using the QuickChange site-directed mutagenesis kit (Agi-
lent). Plasmids were transfected using Lipofectamine® 2000 (Invitrogen) in Opti-
MEMTM (Gibco) containing 10% FBS. Twenty-four hours after transfection, cells
were used for GFP-pulldown or ﬂuorescence microscopy.
RNA interference. Proteins were depleted by two sequential transfections with 40
nM siRNA (Dharmacon, GE Healthcare) using Lipofectamine® RNAiMAX
(Invitrogen) in Opti-MEMTM (Gibco) containing 10% FBS. The following siRNAs
were used:
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5′-CGUACGCGGAAUACUUCGA-3′ (Luciferase);
5′-GCAAGGAAGCAGUGCGUUAUU-3′ (TCP1-1);
5′-GACCAAAUUAGACAGAGAUU-3′ (TCP1-2);
5′-GAACUGAGUGACAGAGAAAUU-3′ (CCT4-1);
5′-GUGUAAAUGCAGUGAUGAAUU-3′ (CCT4-2);
5′-GCAAAUACAAUGAGAACAUUU-3′ (CCT5-1);
5′-CAACACAAAUGGUUAGAAUUU-3′ (CCT5-2);
5′-CUGACAACUUUGAAGCUUUUU-3′ (CCT7-1);
5′-GGCAAUUGUUGAUGCUGAGUU-3′ (CCT7-2);
5′-UGAUAAUGGUGUUGUGUUUUU-3′ (DDB1-1);
5′-AGAGAUUGCUCGAGACUUUUU-3′ (DDB1-2).
UV-C irradiation. UV damage was induced using a 254-nm TUV PL-S 9W lamp
(Philips).
Treatment with TRiC inhibitor. Medium supplemented with 2.5 mM 2-[(4-
chloro-2λ4,1,3-benzothiadiazol-5-yl)oxy]acetic acid (Vitas-M Laboratory Ltd., via
MolPort-002-507-960) was added to attached cells in six-well plates every 24 h
during 72 h.
Western blotting. Proteins were separated in 4–12% Bis-Tris NuPAGE® gels
(Invitrogen) or CriterionTM gels (Bio-Rad) in MOPS (Life Technologies). For the
detection of (endogenous) CSA by the Abcam rabbit CSA antibody, hand casted
10% or 13% acrylamide gels were used and electrophoresis was performed in a
Tris-Glycine-SDS buffer. Separated proteins were blotted onto PVDF membranes
(Millipore), which were incubated with the following primary antibodies: rabbit α-
FLAG (Sigma, F7425; 1:2000); mouse α-Tubulin (Sigma, T6199; 1:5000); mouse α-
GFP (Roche, #11814460001; 1:1000); mouse α-RNAPIIo (Abcam, ab5408; 1:1000);
goat α-DDB1 (Abcam, ab9194; 1:1000); rabbit α-CSA/ERCC8 (Abcam, ab137033;
1:1000); rabbit α-H3 (Abcam, ab1791; 1:5000); rabbit α-CSB/ERCC6 (Santa Cruz
Biotechnology, sc-25370; 1:1000); goat α-CSB/ERCC6 (Santa Cruz Biotechnology,
sc-10459; 1:1000); mouse α-CCT4 (Santa Cruz Biotechnology, sc-137092; 1:500);
rabbit α-CUL4A (Bethyl Laboratories, A300-739A; 1:500); mouse α-TCP1
(Abnova, H00006950-M01; 1:1000); mouse α-CCT5 (Abnova, H00022948-M01;
1:500); mouse α-CCT7 (Abnova, H00010574-M01; 1:500). Protein bands were
visualized using the Odyssey® Imaging System (LI-COR) after incubation with
CFTM dye labeled secondary antibodies (Sigma; 1:10,000), or detected by the
ECLTM Prime Western Blotting system (GE Healthcare) following incubation with
Horseradish Peroxidase-conjugated secondary antibodies (Dako; 1:5000).
Immunoprecipitations and pulldowns. Cells were lysed in IP buffer (30 mM Tris
pH 7.5, 150 mM NaCl, 2 mMMgCl2, 0.5% Triton X-100, protease inhibitor cocktail
(Roche)) during 1 h at 4 °C. The supernatant obtained by centrifugation is referred
to as the soluble fraction, while the solubilized chromatin fraction was prepared by
resuspension of the pellet followed by 1–2 h of incubation in IP buffer containing
250 U/mL Benzonase® Nuclease (Novagen). Samples were subsequently incubated
with the indicated antibody for immunoprecipitation during 2–4 h.
For immunoprecipitation of proteins from total cell extracts, cells were directly
lysed in IP buffer supplemented with 250 U/mL Benzonase® nuclease and the
desired antibody. Protein complexes were pulled down during 1–2 h incubation
with Protein A agarose beads (Millipore). GFP-tagged proteins were precipitated
using GFP-Trap®_A beads (Chromotek), while FLAG-tagged proteins were
precipitated using ANTI-FLAG® M2 Afﬁnity Agarose Gel (Sigma). For tandem
puriﬁcation, proteins were eluted from the beads by addition of 3× FLAG peptide
(Sigma). For subsequent analysis by western blotting, proteins were eluted by
boiling of the beads in Laemmli-SDS sample buffer.
Determination of overall protein levels by western blotting. For detection of
overall protein levels, whole-cell extracts were prepared by lysis in 5 µL IP buffer
(30 mM Tris pH 7.5, 150 mM NaCl, 2 mM MgCl2, 0.5 % Triton X-100, protease
inhibitor cocktail (Roche)) per 100,000 cells during 10 min at room temperature.
Equal volumes of Laemmli-SDS sample buffer were added and the samples were
heated at 95 °C for 10 min prior to western blot analysis.
Fluorescence microscopy. Cells were grown on glass coverslips and subjected to
the indicated treatments. Cells were washed with PBS and ﬁxed with 2% for-
maldehyde (Sigma) in PBS. For nuclear staining, cells were permeabilized in 0.25%
Triton X-100 (Sigma) and incubated with DAPI (Sigma). Images were acquired on
a Zeiss AxioImager D2 wideﬁeld ﬂuorescence microscope equipped with ×40, ×63,
and ×100 PLAN APO (1.4 NA) oil-immersion objectives (Zeiss) and an HXP 120
metal-halide lamp used for excitation. Images were recorded using ZEN
2012 software and analyzed in ImageJ (https://imagej.nih.gov/ij/).
Identiﬁcation of CSA-interacting proteins. For stable isotope labeling of amino
acids in culture (SILAC), cells were grown in DMEM containing 10% dialyzed FBS
(Gibco), 10% GlutaMAX (Life Technologies), penicillin/streptomycin (Life Tech-
nologies), unlabeled L-arginine-HCl and L-lysine-HCL or 13C6,15N4L-arginine-HCl
and 13C6,15N2L-lysine-2HCL (Cambridge Isotope Laboratories), respectively. FLAG
and CSA-FLAG complexes were pulled down from total cell extracts with ANTI-
FLAG® M2 Afﬁnity Gel (Sigma) and extensively washed. Bound proteins were
eluted with FLAG peptide (0.2 mg/mL in PBS), separated in SDS-PAGE gels and
visualized with Coomassie (SimplyBlue; Invitrogen). SDS-PAGE gel lanes were cut
into 2-mm slices and subjected to in-gel reduction with dithiothreitol, alkylation
with iodoacetamide (98%; D4, Cambridge Isotope Laboratories) and digestion with
trypsin (sequencing grade; Promega). Nanoﬂow liquid chromatography tandem
mass spectrometry (LC-MS/MS) was performed on an 1100 series capillary liquid
chromatography system (Agilent Technologies) coupled to a Q-Exactive mass
spectrometer (Thermo Scientiﬁc) operating in positive mode. Peptide mixtures
were trapped on a ReproSil C18 reversed phase column (1.5 cm × 100 μm) at a rate
of 8 μL/min, separated using a linear gradient of 0–80% acetonitrile (in 0.1% formic
acid) during 60 min at a rate of 200 nL/min using a splitter. The eluate was directly
sprayed into the electrospray ionization (ESI) source of the mass spectrometer.
Spectra were acquired in continuum mode; fragmentation of the peptides was
performed in data-dependent mode. Mass spectrometry data were analyzed with
MaxQuant software (version 1.1.1.25).
LFQ and cross-linking mass spectrometry. LFQ, stoichiometry estimation, and
cross-linking mass spectrometry were performed essentially as described pre-
viously20,21. Brieﬂy, GFP immunoprecipitations for LFQ and stoichiometry ana-
lysis were performed in triplicate using ChromoTek GFP-Trap beads or control
non-GFP beads and 2 mg of whole-cell lysate collected in a 1% NP-40 whole-cell
lysis buffer. After protein incubation, two washes were performed with 1M NaCl
and 1% NP-40, followed by additional washes with PBS. Reduction and alkylation
were performed in-solution, and samples were digested with trypsin overnight.
Tryptic peptides were separated over a 120 min gradient from 7 to 32% acetonitrile
with 0.1% formic acid and measured on a Thermo Q-Exactive mass spectrometer.
Identiﬁcation and quantiﬁcation of peptides were performed using MaxQuant
version 1.5.1.049. Relative stoichiometries were calculated by normalizing each
protein by iBAQ value against the bait protein (CSA).
For cross-linking mass spectrometry, two independent experiments were
conducted. Protein puriﬁcations and mass spectrometry analysis were essentially
the same as stated above, with exceptions noted below. First, after washes, we cross-
linked immunoprecipitated complexes on-bead for 1 h at room temperature using
1 mM BS3 (bis(sulfosuccinimidyl)suberate) in 50 mM borate buffered saline.
Cross-linking was quenched with 100 mM ammonium bicarbonate for ten minutes
and sample preparation for mass spectrometry was continued as previously,
including reduction, alkylation, and digestion. Samples were measured on either a
Thermo QExactive or a Thermo Fusion as above, but over a 4 h 7–37% acetonitrile
gradient with charge 2+ or lower masses excluded from fragmentation. Cross-
linked peptides were identiﬁed using pLink22 with an FDR of 0.05. Identiﬁed cross-
links were further ﬁltered to remove matches were either peptide was not ≥5 or ≤40
amino acids in length and with an e-value for the spectral match of ≤0.0001. All
identiﬁed cross-links in any experiment meeting these criteria were combined for
further analysis. Cross-linking data were structurally validated using a TRiC
homology model where each subunit was produced using Phyre2 and aligned onto
the eukaryotic TRiC in Chimera (PDB: 4V9450,51). In cases where a cross-linked
residue was not resolved in the structure, the nearest structurally resolved residue
in the protein sequence was used for modeling. All structural images were
produced in UCSF Chimera, and cross-link distance analysis was performed using
XlinkAnalyzer52,53. Accessible interaction space was modeled using DisVis23 and
human CSA (PDB: 4A116).
RNA synthesis recovery assay. Cells were seeded in 96-well plates, transfected
with siRNAs (see above) and after 48 h irradiated with UV-C (10 J/m2), and
incubated for different time-periods (0–30 h) to allow RNA synthesis recovery.
RNA was labeled for 1 h in medium supplemented with 1 mM EU (Click-iT® RNA
Alexa Fluor® 594 Imaging Kit, Life Technologies) according to the manufacturer’s
instructions. Imaging was performed on an Opera Phenix confocal High-Content
Screening System (Perkin Elmer, Hamburg, Germany) equipped with solid state
lasers. General nuclear staining (DAPI) and Alexa 594 were serially detected in
nine ﬁelds per well using a ×20 air objective. Three independent experiments were
analyzed using a custom script in the Harmony 4.5 software (Perkin Elmer) in
which nuclei were individually segmented based on the DAPI signal. RNA
synthesis recovery was determined by measuring the mean Alexa 594 intensity of
all nuclei per well.
DNA synthesis repair assay. Cells were seeded on coverslips and transfected with
siRNA (see above). After 48 h, the cells were UV-C irradiated (20 J/m2) and sub-
sequently DNA was labeled for 3 h in medium supplemented with 1 µM of EU
(Click-iT® DNA Alexa Fluor® 488 Imaging Kit, Life Technologies) according to the
manufacturer’s instructions. DNA synthesis repair was quantiﬁed by determining
ﬂuorescence intensities for >20 cells with ImageJ software of images obtained with
a Zeiss LSM700.
UV and Illudin S survival assays. Cells were seeded at low density and UV-C
irradiated at different doses or treated with 300, 600, and 1000 pg/mL Illudin S
(Santa Cruz; sc-391575) for 72 h. After 11–14 days of incubation, cells were
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washed with 0.9% NaCl and stained with methylene blue. Colonies of >20 cells
were scored.
Cell viability (alamarBlue) assay. Cells were seeded in 96-well plates, transfected
with siRNAs (see above) and after 48 h irradiated with UV-C (10 J/m2). Alamar-
Blue® (Life Technologies) was added and ﬂuorescence was measured 72 h later
according to the manufacturer’s instructions.
Data availability. The data sets generated and analyzed during the current study
have been deposited to the ProteomeXchange Consortium via the PRIDE partner
repository with the data set identiﬁers PXD008863 and PXD008868. Other relevant
data generated during the current study are available from the corresponding
authors on reasonable request.
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